Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable)

Transcription

1 Support to patient organisations 2014: (SPONSORSHIP) *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Total Amount Paid (GBP) Description of the Support UK Virology - HIV National AIDS Trust Sponsorship of PAG activities - Financial Support Sponsorship of NATs Policy Network activities related to the NHS England 14,000 HIV Clinical Reference Group. UK Virology - HIV National Aids Map Sponsorship of PAG activities - Financial Support Part sponsorship of HIV - Women and Pregnancy leaflet update and production UK Virology - HCV Hepatitis Scotland Sponsorship of PAG activities - Financial Support Co-Sponsorship of Hepatitis C Patient Conference 2,500 UK Virology - HCV Hepatitis C Trust Sponsorship of PAG activities - Indirect financial Support BMS will provide indirect financial support in the form of the time of Insight Public Affairs to assist in this activity. Under the direction of HCV Action (a sub group of Hep C Trust), Insight PA will audit JSNAs and HWB Strategies to determine the level of priority assigned to Hep C 4,000 UK Virology - HCV Hepatitis C Trust Sponsorship of PAG activities - Financial Support Financial support for HCV Action Group 22,000 UK Virology - HCV Hepatitis C Trust Partnership Joint PAG/BMS - Financial Financial support for radio day 418 UK Virology - HCV Homeless Link Partnership Joint PAG/BMS - Indirect Financial Support Sponsorship of a policy task force via indirect financial support (up to the 20,738 value of 35,000)* in the form of the time of Insight Public Affairs who will provide secetariat functions. In practice support to the value of 20,738 was provided UK Oncology Rarer Cancers foundation Sponsorship of PAG activities - Financial Support Financial support for Industry Reference Group 18,000 UK Oncology Melanoma UK Sponsorship of PAG activities - Financial Support Financial support for the provision of patient support activities 15,000 UK Oncology SKCIN Sponsorship of PAG activities - Indirect financial Support Indirect financial support for communication and stakeholder activities 12,500 UK Oncology Cancer 52 Sponsorship of PAG activities - Financial Support Financial support for stakeholder outreach programme UK Oncology Cancer Campaigning Group Sponsorship of PAG activities - Financial Support Financial support for government affairs activities UK Oncology CML Support Sponsorship of PAG activities - Financial Support Financial support for stakeholder outreach programme UK Oncology Leukeamia Care Sponsorship of PAG activities - Financial Support Financial support for nurse conference UK Oncology Melanoma UK Sponsorship of PAG activities - Indirect financial Support Indirect support for the development of a melanoma dashboard 80,940 Europe Oncology Teenage Cancer trust Sponsorship of PAG activities - Financial Support Financial support for their conference 3,000 Europe Oncology Melanoma UK Sponsorship of PAG activities - Indirect financial Support Indirect financial support for stakeholder outreach programme 16,196 UK Oncology Melanoma UK Sponsorship of PAG activities - Indirect financial Support Indirect support for melanoma meeting 7,418 UK Oncology Melanoma UK Sponsorship of PAG activities - Indirect financial Support Indirect financial support for communication and stakeholder activities 12,500 UK Rheumatoid Arthritis National Rheumatoid Arthritis Society Sponsorship of PAG activities - Financial Support Part sponsorship of RA Awareness Week 3,500 UK Rheumatoid Arthritis National Rheumatoid Arthritis Society Sponsorship of PAG activities - Financial Support Part sponsorship of NRAS Annual Patient Conference 1,500 UK Rheumatoid Arthritis Arthritis Care Sponsorship of PAG activities - Financial Support Sponsorship of Regional Patient Self-Management Programme 3,759 UK Cardiovascular AF Association Sponsorship of PAG activities - Financial Support * The BMS-Pfizer Alliance made a payment towards the costs of AF 30,000 Association s regional patient education programme on AF UK Cardiovascular Anticoagulation Europe Sponsorship of PAG activities - Financial Support * The BMS-Pfizer Alliance provided funding to enable Anticoagulation Europe to provide the Secretariat to the All-Party Parliamentary Group on Thrombosis for the first half of 2014 UK Cardiovascular Anticoagulation Europe Sponsorship of PAG activities - Financial Support * The BMS-Pfizer Alliance made a payment towards the costs of Anticoagulation Europe s regional patient education meetings 7,500 9,750 UK Cardiovascular Arrhythmia Alliance Sponsorship of PAG activities - Financial Support * The BMS-Pfizer Alliance paid for sponsorship of the Arrhythmia Alliance s Cardiac Update meeting series for healthcare professionals in 2013 and 2014 (2013 payment made in 2014) UK Cardiovascular Arrhythmia Alliance Sponsorship of PAG activities - Financial Support * The BMS-Pfizer Alliance paid for sponsorship of the Arrhythmia Alliance s 10th Anniversary parliamentary event in Westminster UK Cardiovascular Arrhythmia Alliance Sponsorship of PAG activities - Financial Support * The BMS-Pfizer Alliance made a payment towards the Arrhythmia Alliance s organisation of a launch event in the EU Parliament in Brussels, and European-wide roll-out, of a report on Atrial Fibrillation in Europe UK Cardiovascular Stroke Association Sponsorship of PAG activities - Financial Support * The BMS-Pfizer Alliance made a payment towards the cost of the Stroke Association s Ask First campaign, an educational campaign on atrial fibrillation aimed at healthcare professionals, patients and the general public UK Cardiovascular Stroke Association Sponsorship of PAG activities - Financial Support * The BMS-Pfizer Alliance paid for a sponsorship package at the 2014 UK Stroke Forum, organised by the Stroke Association ,750 20,000 8,500 Sub total 407,644

2 Patient organisations engaged to provide significant contracted services 2014: (FEE FOR SERVICE) *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Description of the Support UK Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance Advisory Board meeting which took UK Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance Advisory Board meeting which took place in the Europe UK Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance Advisory Board meeting which took UK Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance Advisory Board meeting which took UK Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honoraria for preparation time and participation of an AF Association staff member in BMS-Pfizer Alliance Patient Group Summit which took place in Europe UK Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Travel* * The BMS-Pfizer Alliance paid expenses to one AF Association staff member in relation to their participation in a BMS-Pfizer Alliance Patient Group Summit which took place in Europe: Flights = / Accommodation = / Transfers = UK Cardiovascular Stroke Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of a Stroke Association staff member in a BMS-Pfizer organised radio day on atrial fibrillation UK Cardiovascular Stroke Association Advocacy Meetings Fee for Service* *The BMS-Pfizer Alliance contracted the Stroke Association to provide a speaker at four BMS-Pfizer Alliance organised regional meetings for healthcare professionals, commissioners and policymakers on atrial fibrillation Total Amount Paid (GBP) , Sub total 5,268 Grants Donations Sponsorship of PAG activities - Financial Support Sponsorship of PAG activities - Non-financial Support Sponsorship of PAG activities - Indirect financial Support Partnership Joint PAG/BMS - Financial Partnership Joint PAG/BMS - Non-financial Partnership Joint PAG/BMS - Indirect Financial Support Sponsorship of PAG members to attend events and congresses Advocacy Meetings Use of a PAG member as a speaker at a non-promotional meeting Advisory Board

3 Support to patient organisations 2013: (SPONSORSHIP) *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the Diabetes Alliance (an alliance between Bristol-Myers Squibb and AstraZeneca), the cost of which was split 50:50. **All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Total Amount Paid (GBP) Description of the Support UK Diabetes African Eye Trust Sponsorship of PAG activities - Financial Support Diabetes Booklet and Advocate Training* 6,500 UK Diabetes Silver Star Sponsorship of PAG activities - Financial Support Acknowledgement of Alliance sponsorship on Patient Charity agenda, stands 4,000 and event literature* UK Diabetes Silver Star Sponsorship of PAG activities - Financial Support Acknowledgement of Alliance sponsorship on Patient Charity agenda, stands 4,000 and event literature* UK Diabetes Silver Star Sponsorship of PAG activities - Financial Support Acknowledgement of Alliance sponsorship on Patient Charity agenda, stands 4,750 and event literature* UK Cardiovascular Atrial Fibrillation Association Donations BMS-Pfizer Alliance made a donation to support the AF Association s AF 8,735 awareness activities as part of AF AWARE Week ** UK Cardiovascular Atrial Fibrillation Association Sponsorship of PAG activities - Financial Support Publication and dissemination of the AF Association s Grasp The Initiative 2,793 report to GP practices ** UK Cardiovascular Atrial Fibrillation Association Sponsorship of PAG activities - Financial Support BMS-Pfizer Alliance sponsored the launch meeting for the AF Association's GP Revalidation Tool at the Best Practice conference ** 750 UK Cardiovascular Atrial Fibrillation Association Sponsorship of PAG activities - Financial Support BMS-Pfizer Alliance provided funding towards the development of the Grasp the Initiative: Action Plan report, which was initiated by the AF Association and the BMS-Pfizer Alliance** UK Cardiovascular Atrial Fibrillation Association Sponsorship of PAG activities - Financial Support BMS-Pfizer Alliance provided funding to enable the Atrial Fibrillation Association to provide the Secretariat to the All-Party Parliamentary Group on Atrial Fibrillation** UK Cardiovascular Anticoagulation Europe Donations BMS-Pfizer Alliance made a donation towards the development costs of Anticoagulation Europe s website and mobile application project entitled Improving Patient Education on Oral Anticoagulants.** UK Cardiovascular Anticoagulation Europe Donations BMS-Pfizer Alliance made a donation towards the development of a hard copy guide derived from Anticoagulation Europe s website and mobile application project entitled Improving Patient Education on Oral Anticoagulants above** UK Cardiovascular Arrhythmia Alliance Donations BMS-Pfizer Alliance made a donation towards Arrhythmia Alliance s Global Education Programme on atrial fibrillation and atrial fibrillation-related stroke** UK Cardiovascular Arrhythmia Alliance Sponsorship of PAG activities - Financial Support BMS-Pfizer Alliance paid for a sponsorship package for the 2013 Heart Rhythm Congress ** UK Cardiovascular Lifeblood: The Thrombosis Charity Donations BMS-Pfizer Alliance made a donation to support Lifeblood s National Thrombosis Week campaign and associated thrombosis education activities for healthcare professionals and patients** UK Cardiovascular Stroke Association Donations BMS-Pfizer Alliance made a donation towards the production and print costs of 15,000 copies of the Stroke Association s patient information sheet entitled Atrial fibrillation (AF) and stroke.** Europe Cardiovascular AntiCoagulation Europe (UK) Donations BMS-Pfizer Alliance made a donation towards the development costs of Anticoagulation Europe s website and mobile application project entitled Improving Patient Education on Oral Anticoagulants. 17,500 9,750 5,000 15,000 13,455 2,000 2,000 12,383 Europe Cardiovascular Arrhythmia Alliance (UK) Donations BMS-Pfizer Alliance made a donation towards Arrhythmia Alliance s Global 19,050 Education Programme on atrial fibrillation and atrial fibrillation-related stroke UK Oncology Cancer Campaigning Group Sponsorship of PAG activities - Financial Support Support for the CCG outreach programme to policy makers UK Oncology CML Support Sponsorship of PAG activities - Financial Support Support for a stakeholder outreach programme to a cross section of CML stakeholders UK Oncology Leukeamia Care Sponsorship of PAG activities - Financial Support Held on the 23:11:13 in Worcester for nurses. The conference was acredited by the RCN for 7 study hours and was about providing nurses with the knowledge to support patients through the pathway UK Oncology Macmillan Sponsorship of PAG activities - Financial Support Support for the Britain Against Cancer conference held in December 2013 in London 6,900 UK Oncology Melanoma UK Sponsorship of PAG activities - Financial Support Melanoma UK, on behalf of the Melanoma Taskforce built a website to showcase the taskforces work and reports, support was provided for this UK Oncology Melanoma UK Sponsorship of PAG activities - Indirect financial Support This was a survey of patient experience of the melanoma patient pathway, which was then written up and published on the Melanoma UK website 4,000 14,740

4 UK Oncology Melanoma UK Sponsorship of PAG activities - Financial Support To support the attendance of Melanoma UK representive at a Melanoma Taskforce Meeting in Westminster UK Oncology OcuMel UK Sponsorship of PAG activities - Financial Support OcuMel is a PAG for patients with ocular melanoma. Their conference "Developing Excellence in Ocular Melanoma" took place in Reading on the 23rd September last year UK Oncology Orchid Sponsorship of PAG activities - Financial Support Support was provided for Orchid to build a website on behalf of prostate cancer stakehodlers to enable remote interaction on issues for the BME community around prostate cancer 300 1,000 3,000

5 UK Oncology Rarer Cancers foundation Sponsorship of PAG activities - Financial Support To support the RCF Industry Reference Group as a member. 18,000 UK Virology Baseline magazine Sponsorship of PAG activities - Financial Support Sponsored article placement in patient HIV magazine, tri yearly 2,000 UK Virology Hepatitis C Trust Partnership Joint PAG/BMS - Financial Shaping the Policy aims of the Hepatitis C Action Group and supporting their 5,500 delivery Europe Virology/HIV Treat.info UK Robert Fieldhouse EMEA Non-Clinical Donation To support the handover of the BEST Programme 50,000 Patient organisations engaged to provide significant contracted services 2013: (FEE FOR SERVICE) *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the Diabetes Alliance (an alliance between Bristol-Myers Squibb and AstraZeneca), the cost of which was split 50:50. **All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Description of the Support UK Cardiovascular Anticoagulation Europe Use of a PAG member as a speaker at a non-promotional meeting Fee for Service** Honorarium for the participation of an Anticoagulation Europe staff member in a BMS-Pfizer Alliance internal training day UK Cardiovascular Anticoagulation Europe Use of a PAG member as a speaker at a non-promotional meeting Fee for Service** BMS-Pfizer Alliance paid an honorarium for the participation of an Anticoagulation Europe staff member in a BMS-Pfizer Alliance internal training day UK Cardiovascular Anticoagulation Europe Advisory Board Fee for Service** BMS-Pfizer Alliance paid an honorarium for the participation of an Anticoagulation Europe staff member in a BMS-Pfizer Alliance European Advisory Board meeting which took UK Cardiovascular Anticoagulation Europe Advisory Board Fee for Service** BMS-Pfizer Allaince paid an honoraria for an AntiCoagulation Europe staff member to advise on the creation of a BMS-Pfizer European policy report on stroke prevention in atrial fibrillation UK Cardiovascular Anticoagulation Europe Advisory Board Fee for Service** BMS-Pfizer Alliance paid an honorarium for the participation of an Anticoagulation Europe staff member in a BMS-Pfizer Alliance European Advisory Board meeting which took place in Europe UK Cardiovascular Anticoagulation Europe Sponsorship of PAG activities - Financial Support Travel** BMS-Pfizer Alliance paid travel expenses for the one staff member to travel to a BMS- Pfizer Alliance European Advisory Board meeting which took place in Europe (Transfers value = 111**) UK Cardiovascular Atrial Fibrillation Association Advisory Board Fee for Service** Honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance European Advisory Board meeting UK Cardiovascular Atrial Fibrillation Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service** BMS-Pfizer Alliance paid an honorarium for an AF Association staff member to advise on the creation of a European policy report on stroke prevention in atrial fibrillation. UK Cardiovascular Atrial Fibrillation Association Advisory Board Travel** The BMS-Pfizer Alliance paid travel expenses for the two staff members to travel and stay overnight in a hotel (Travel flights and transfers (value = 123**) to the BMS- Pfizer Alliance European Advisory Board meeting which took UK Cardiovascular Atrial Fibrillation Association Advisory Board Travel** BMS-Pfizer Alliance paid expenses to one AF Association staff member in relation to their participation in a BMS-Pfizer Alliance European Advisory Board meeting which took place in Europe (Transfers = 87**; Travel = 131**) Total Amount Paid (GBP) , , Europe Cardiovascular Atrial Fibrillation Association (UK) Advisory Board - Fee for service/speaker services partnership Fee for Service BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association 381 Europe Cardiovascular AntiCoagulation Europe (UK) Advisory Board - Fee for service/speaker services partnership Fee for Service BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association 381 Europe Cardiovascular AntiCoagulation Europe (UK) Advisory Board - Fee for service/speaker services partnership Fee for Service BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association 394 Europe Diabetes National Obesity Forum (UK) Advisory Board - Fee for service/speaker services partnership Fee for Service BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association Europe Diabetes AntiCoagulation Europe (UK) Advisory Board - Fee for service/speaker services partnership Fee for Service BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association Europe Diabetes Atrial Fibrillation Association (UK) Advisory Board - Fee for service/speaker services partnership Fee for Service BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association Europe Rheumatoid Arthritis Arthritis Ireland Advisory Board - Fee for service/speaker services partnership Fee for Service PRO Active advisory board November UK Virology Positively UK Partnership Joint PAG/BMS - Financial Patient Partnership Agreement and Fee for service Sponsorship of PLWHIV conference and Stand space at conference 5,000 UK Virology Eyes Open Partnership Joint PAG/BMS - Financial Fee for Service Stand Space at World Aids day one day Conference North East 1,000

6 Grants Donations Sponsorship of PAG activities - Financial Support Sponsorship of PAG activities - Non-financial Support Sponsorship of PAG activities - Indirect financial Support Partnership Joint PAG/BMS - Financial Partnership Joint PAG/BMS - Non-financial Partnership Joint PAG/BMS - Indirect Financial Support Sponsorship of PAG members to attend events and congresses Advocacy Meetings Use of a PAG member as a speaker at a non-promotional meeting Advisory Board

7 Support to patient organisations 2012: (SPONSORSHIP) * Where payments were made from the BMS-Pfizer Alliance, amounts shown are BMS contribution, which was 50% in all cases to the total payment Patient Advocacy Group Name Support Description of the Contracted Services (when applicable) Amount (in Pounds) Access CML Drugs Sponsorship of joint PAG/BMS activities - In kind support Use of BMS government affairs agency to create briefings on the environment in 1,456 cancer Anticoagulation Europe Sponsorship of joint PAG/BMS activities - Financial Support BMS-Pfizer Alliance paid for development costs of a guide to anticoagulation for 5,000 patients* Anticoagulation Europe Sponsorship of joint PAG/BMS activities - Financial Support BMS-Pfizer Alliance paid for sponsorhip of Anticoagulation in Practice Conference 2,000 Arrhythmia Alliance (A-A) Sponsorship of joint PAG/BMS activities - Financial Support BMS-Pfizer Alliance paid for stand at the 2012 Heart Rhythm Congress, which is organised by the Arrhythmia Alliance* Atrial Fibrillation Association Sponsorship of joint PAG/BMS activities - Financial Support BMS-Pfizer Alliance made a donation towards the development and production costs of a GP revalidation toolkit * Atrial Fibrillation Association Sponsorship of joint PAG/BMS activities - Financial Support BMS-Pfizer Alliance provided funding to enable the Atrial Fibrillation Association to provide the Secretariat to the All-Party Parliamentary Group on Atrial Fibrillation* Atrial Fibrillation Association Sponsorship of joint PAG/BMS activities - Financial Support BMS-Pfizer Alliance provided funding towards the development of the Grasp the Initiative report, which was initiated by the AF Association and the BMS-Pfizer Alliance* Atrial Fibrillation Association (AF Association) Sponsorship of joint PAG/BMS activities - In kind support BMS-Pfizer communications agency in-kind support - Communications skills sessions for the AF Association* Atrial Fibrillation Association (AF Association) Sponsorship of joint PAG/BMS activities - In kind support BMS-Pfizer communications agency in-kind support -Filming of AF patients for use in AF Association activities* Atrial Fibrillation Association (AF Association) Sponsorship of joint PAG/BMS activities - In kind support BMS-Pfizer public affairs agency in-kind support. Development of the Grasp the Initiative report, initiated by the AF Association and the BMS-Pfizer Alliance* 1,925 12,500 17,500 12,500 8, ,500 British Liver Trust Sponsorship of joint PAG/BMS activities - Financial Support Primary Care Workshop programme 10,000 British Liver Trust Sponsorship of joint PAG/BMS activities - In kind support Couriering materials to nursing trade show for BLT 24 Cancer Campaigning Group Sponsorship of joint PAG/BMS activities - Financial Support Support for Campaigning Activities 10,000 Cancer52 Sponsorship of joint PAG/BMS activities - Financial Support Support their own government affiars programme and campaigning activities 7,500 CML Support Sponsorship of joint PAG/BMS activities - Financial Support support for Campaigning activities 10,000 CRUK Sponsorship of joint PAG/BMS activities - Financial Support Project to support piloting of GP melanoma decision support toolkit 66,000 Factor 50 Sponsorship of joint PAG/BMS activities - Financial Support Production of patient support packs 10,000 Factor 50 Sponsorship of joint PAG/BMS activities - In kind support Use of BMS government affairs agency political expertise to support campaigning 10,000 activities Leukaemia CARE Sponsorship of joint PAG/BMS activities - Financial Support Nurse Conference Production 10,000 Lifeblood Sponsorship of joint PAG/BMS activities - Financial Support BMS-Pfizer Alliance made a donation to support Lifeblood s National Thrombosis 1,250 Week campaign and associated thrombosis education activities for healthcare professionals and patients * MacMillan Sponsorship of joint PAG/BMS activities - Financial Support Britain Against Cancer Conference 7,000 Men's Health Forum Sponsorship of joint PAG/BMS activities - Financial Support Update of the Men and Cancer Manual 10,000 Men's Health Forum Sponsorship of joint PAG/BMS activities - Financial Support Men and Cancer Round Table 12,500 NAM Sponsorship of joint PAG/BMS activities - Financial Support Support of NAM for the Interactive HIV Woment Talking Points tool 9,750 National Aids Trust Sponsorship of joint PAG/BMS activities - Financial Support Support of HIV Networking Project with 3 Networks that NAT manage 10,000 National Rheumatoid Arthritis Society Sponsorship of joint PAG/BMS activities - Financial Support To provide information stands for Rheumatology Units, support for recruitment 10,000 and training of peer to peer telephone support volunteers and develop an online training tool, and to extend the existing NRAS Ambassador Programme into Wales and Northern Ireland. OcuMel UK Sponsorship of joint PAG/BMS activities - Financial Support Support for conference production 1,000 Rarer Cancers Foundation Sponsorship of joint PAG/BMS activities - Financial Support Support RCF campaigning activities 18,000 SKCIN Sponsorship of joint PAG/BMS activities - In kind support Use of BMS government affairs agency political expertise to support campaigning activities 10,000

8 Patient organisations engaged to provide significant contracted services 2012: (FEE FOR SERVICE) * Where payments were made from the BMS-Pfizer Alliance, amounts shown are BMS contribution, which was 50% in all cases to the total payment Patient Advocacy Group Name Support Description of the Contracted Services (when applicable) Amount (in Pounds) Anticoagulation Europe Fee for Service BMS-Pfizer Alliance paid for consultancy services on the development of a patient 250 information booklet on atrial fibrillation* Anticoagulation Europe Fee for Service BMS-Pfizer Alliance paid for one ACE staff member to be featured in a BMS-Pfizer 269 Alliance educational video* Anticoagulation Europe Fee for Service BMS-Pfizer Alliance paid for one one staff member to participate in six planning 1,394 meetings for an education and advocacy programme* Atrial Fibrillation Association Fee for Service BMS-Pfizer Alliance paid for consultancy services on the development of a patient 250 information booklet on atrial fibrillation* Atrial Fibrillation Association Fee for Service BMS-Pfizer Alliance paid for one AF Association staff member to be featured in a 269 BMS-Pfizer Alliance educational video* Atrial Fibrillation Association Fee for Service BMS-Pfizer Alliance paid one staff member for participation in an Advisory Board regarding patient insight research* 150 Atrial Fibrillation Association Fee for Service PAG member participated in a series of six planning meetings for an education and 1,349 advocacy programme* Atrial Fibrillation Association Fee for Service BMS-Pfizer Alliance paid for one AF Association staff member to participate in a 532 BMS-Pfizer Alliance European Advisory Board meeting* Atrial Fibrillation Association Fee for Service BMS-Pfizer Alliance paid for one AF Association staff member to participate in a 664 BMS-Pfizer Alliance European Advisory Board meeting* Atrial Fibrillation Association Fee for Service BMS-Pfizer Alliance paid for two AF Association representatives to participate in a 750 European atrial fibrillation patient advocacy meeting which was organised by the BMS-Pfizer Alliance* BASELINE (Robert Fieldhouse) Fee for Service Advisory Board attendance at AIDS BASELINE (Robert Fieldhouse) Fee for Service Advisory Board for for non-promotional medical education peer support 596 British Liver Trust Fee for Service Use of a PAG member as a speaker at a non-promotional meeting 240 CML Support Fee for Service Consultancy fee for advice given on 25/01/2012 linked to a CML advisory board 360 held late 2011 CNHLC Fee for Service Use of a PAG member as a speaker at a non-promotional meeting 240 Positively UK Fee for Service Use of PAG member at Advisory Board for non-promotional medical education 1,457 peer support training Positively UK Fee for Service Use of PAG member for Advisory Board at AIDS ,590 RestorEGO Consultancy, EATG representative Fee for Service Use of EATG representative at Advisory Board 1,192 RestorEGO Consultancy, EATG representative Fee for Service Use of EATG representative at Advisory Board for non-promotional medical education programme 795 Salamander Trust Fee for Service Advisory board attendance for non-promotional medical education factsheet 397 development Trustee of Waverley Care /EATG Fee for Service Advisory board attendance at AIDS Trustee of Waverley Care /EATG Fee for Service Advisory board attendance for non-promotional medical education peer support training 1,325